ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC34294-50mg |
|
— |
Elacestrant S enantiomer dihydrochloride (RAD1901 S enantiomer dihydrochloride)
|
0 | C30H40Cl2N2O2 | |
GC34294-5mg |
|
— |
Elacestrant S enantiomer dihydrochloride (RAD1901 S enantiomer dihydrochloride)
|
0 | C30H40Cl2N2O2 | |
GC34294-1mg |
|
— |
Elacestrant S enantiomer dihydrochloride (RAD1901 S enantiomer dihydrochloride)
|
0 | C30H40Cl2N2O2 | |
GC34294-10mM(1mLinWater) |
|
— |
Elacestrant S enantiomer dihydrochloride (RAD1901 S enantiomer dihydrochloride)
|
0 | C30H40Cl2N2O2 | |
GC34293-50mg |
|
— |
Elacestrant S enantiomer (RAD1901 S enantiomer)
|
0 | C30H38N2O2 | |
GC34293-10mg |
|
— |
Elacestrant S enantiomer (RAD1901 S enantiomer)
|
0 | C30H38N2O2 | |
GC34293-5mg |
|
— |
Elacestrant S enantiomer (RAD1901 S enantiomer)
|
0 | C30H38N2O2 | |
GC34293-1mg |
|
— |
Elacestrant S enantiomer (RAD1901 S enantiomer)
|
0 | C30H38N2O2 | |
GC34293-10mM(1mLinDMSO) |
|
— |
Elacestrant S enantiomer (RAD1901 S enantiomer)
|
0 | C30H38N2O2 | |
GC34292-100mg |
|
— |
(Ac)Phe-Lys(Alloc)-PABC-PNP
|
0 | C35H39N5O10 | |
GC34292-50mg |
|
— |
(Ac)Phe-Lys(Alloc)-PABC-PNP
|
0 | C35H39N5O10 | |
GC34292-10mg |
|
— |
(Ac)Phe-Lys(Alloc)-PABC-PNP
|
0 | C35H39N5O10 | |
GC34292-5mg |
|
— |
(Ac)Phe-Lys(Alloc)-PABC-PNP
|
0 | C35H39N5O10 | |
GC34292-2mg |
|
— |
(Ac)Phe-Lys(Alloc)-PABC-PNP
|
0 | C35H39N5O10 | |
GC34291-2g |
|
— |
E3 ligase Ligand 1 dihydrochloride
|
0 | C23H34Cl2N4O3S | |
GC34291-1g |
|
— |
E3 ligase Ligand 1 dihydrochloride
|
0 | C23H34Cl2N4O3S | |
GC34291-500mg |
|
— |
E3 ligase Ligand 1 dihydrochloride
|
0 | C23H34Cl2N4O3S | |
GC34291-100mg |
|
— |
E3 ligase Ligand 1 dihydrochloride
|
0 | C23H34Cl2N4O3S | |
GC34291-10mM(1mLinDMSO) |
|
— |
E3 ligase Ligand 1 dihydrochloride
|
0 | C23H34Cl2N4O3S | |
GC34290-5mg |
|
— |
Lurasidone D8 Hydrochloride (SM-13496 D8)
|
0 | C28H29D8ClN4O2S | |